Fairvalue-Calculator Fairvalue-Calculator
EN DE

Honz Pharmaceutical Co (300086) Fair Value & Analysis

Healthcare · CN · Market cap 2.8B CNY

Price¥6.03
Fair Value¥1.32
Upside-78.1%
Quality93/100
Evidence: Medium Range ¥0.9900 – ¥1.98

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Honz Pharmaceutical Co (300086) currently trades at ¥6.03, while our model-based Fair Value estimate is ¥1.32 — implying the stock looks roughly 78.1% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. was founded in 1993 and is based in Guangzhou, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81%

Frequently asked questions

Is Honz Pharmaceutical Co (300086) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥1.32 versus a price of ¥6.03 — about −78% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 300086?
Our 21-model fair value for Honz Pharmaceutical Co is ¥1.32 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥6.03.
What is the quality score of 300086?
Honz Pharmaceutical Co has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.